NCT03508323View on ClinicalTrials.gov

Tenelia Elderly CGMS Study(TEDDY)

PHASE4CompletedINTERVENTIONAL

Enrollment

65

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2019

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Teneligliptin

20mg/qd

DRUG

Placebo

1T/qd

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Handok Inc.

INDUSTRY